BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37203301)

  • 1. mAKAPβ signalosome: A potential target for cardiac hypertrophy.
    Golatkar V; Bhatt LK
    Drug Dev Res; 2023 Sep; 84(6):1072-1084. PubMed ID: 37203301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.
    Kritzer MD; Li J; Passariello CL; Gayanilo M; Thakur H; Dayan J; Dodge-Kafka K; Kapiloff MS
    Circ Heart Fail; 2014 Jul; 7(4):663-72. PubMed ID: 24812305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signalosome-Regulated Serum Response Factor Phosphorylation Determining Myocyte Growth in Width Versus Length as a Therapeutic Target for Heart Failure.
    Li J; Tan Y; Passariello CL; Martinez EC; Kritzer MD; Li X; Li X; Li Y; Yu Q; Ohgi K; Thakur H; MacArthur JW; Ivey JR; Woo YJ; Emter CA; Dodge-Kafka K; Rosenfeld MG; Kapiloff MS
    Circulation; 2020 Dec; 142(22):2138-2154. PubMed ID: 32933333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mAKAPβ signalosomes - A nodal regulator of gene transcription associated with pathological cardiac remodeling.
    Dodge-Kafka K; Gildart M; Tokarski K; Kapiloff MS
    Cell Signal; 2019 Nov; 63():109357. PubMed ID: 31299211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle A-kinase-anchoring protein-β-bound calcineurin toggles active and repressive transcriptional complexes of myocyte enhancer factor 2D.
    Li J; Aponte Paris S; Thakur H; Kapiloff MS; Dodge-Kafka KL
    J Biol Chem; 2019 Feb; 294(7):2543-2554. PubMed ID: 30523159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mAKAP-a master scaffold for cardiac remodeling.
    Passariello CL; Li J; Dodge-Kafka K; Kapiloff MS
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):218-25. PubMed ID: 25551320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A perinuclear calcium compartment regulates cardiac myocyte hypertrophy.
    Turcotte MG; Thakur H; Kapiloff MS; Dodge-Kafka KL
    J Mol Cell Cardiol; 2022 Nov; 172():26-40. PubMed ID: 35952391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bidirectional regulation of HDAC5 by mAKAPβ signalosomes in cardiac myocytes.
    Dodge-Kafka KL; Gildart M; Li J; Thakur H; Kapiloff MS
    J Mol Cell Cardiol; 2018 May; 118():13-25. PubMed ID: 29522762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An adenylyl cyclase-mAKAPbeta signaling complex regulates cAMP levels in cardiac myocytes.
    Kapiloff MS; Piggott LA; Sadana R; Li J; Heredia LA; Henson E; Efendiev R; Dessauer CW
    J Biol Chem; 2009 Aug; 284(35):23540-6. PubMed ID: 19574217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of mAKAPβ in the process of cardiomyocyte hypertrophy induced by angiotensin II.
    Guo H; Liu B; Hou L; The E; Li G; Wang D; Jie Q; Che W; Wei Y
    Int J Mol Med; 2015 May; 35(5):1159-68. PubMed ID: 25739102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mAKAPbeta scaffold regulates cardiac myocyte hypertrophy via recruitment of activated calcineurin.
    Li J; Negro A; Lopez J; Bauman AL; Henson E; Dodge-Kafka K; Kapiloff MS
    J Mol Cell Cardiol; 2010 Feb; 48(2):387-94. PubMed ID: 19883655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipase C epsilon scaffolds to muscle-specific A kinase anchoring protein (mAKAPbeta) and integrates multiple hypertrophic stimuli in cardiac myocytes.
    Zhang L; Malik S; Kelley GG; Kapiloff MS; Smrcka AV
    J Biol Chem; 2011 Jul; 286(26):23012-21. PubMed ID: 21550986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mAKAP signalosome and cardiac myocyte hypertrophy.
    Bauman AL; Michel JJ; Henson E; Dodge-Kafka KL; Kapiloff MS
    IUBMB Life; 2007 Mar; 59(3):163-9. PubMed ID: 17487687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anchored p90 ribosomal S6 kinase 3 is required for cardiac myocyte hypertrophy.
    Li J; Kritzer MD; Michel JJ; Le A; Thakur H; Gayanilo M; Passariello CL; Negro A; Danial JB; Oskouei B; Sanders M; Hare JM; Hanauer A; Dodge-Kafka K; Kapiloff MS
    Circ Res; 2013 Jan; 112(1):128-39. PubMed ID: 22997248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting mAKAPβ expression as a therapeutic approach for ischemic cardiomyopathy.
    Martinez EC; Li J; Ataam JA; Tokarski K; Thakur H; Karakikes I; Dodge-Kafka K; Kapiloff MS
    Gene Ther; 2023 Aug; 30(7-8):543-551. PubMed ID: 35102273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDE4 and mAKAPβ are nodal organizers of β2-ARs nuclear PKA signalling in cardiac myocytes.
    Bedioune I; Lefebvre F; Lechêne P; Varin A; Domergue V; Kapiloff MS; Fischmeister R; Vandecasteele G
    Cardiovasc Res; 2018 Sep; 114(11):1499-1511. PubMed ID: 29733383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UCR1C is a novel activator of phosphodiesterase 4 (PDE4) long isoforms and attenuates cardiomyocyte hypertrophy.
    Wang L; Burmeister BT; Johnson KR; Baillie GS; Karginov AV; Skidgel RA; O'Bryan JP; Carnegie GK
    Cell Signal; 2015 May; 27(5):908-22. PubMed ID: 25683917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A-kinase anchoring proteins: molecular regulators of the cardiac stress response.
    Diviani D; Maric D; Pérez López I; Cavin S; Del Vescovo CD
    Biochim Biophys Acta; 2013 Apr; 1833(4):901-8. PubMed ID: 22889610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RSK3: A regulator of pathological cardiac remodeling.
    Martinez EC; Passariello CL; Li J; Matheson CJ; Dodge-Kafka K; Reigan P; Kapiloff MS
    IUBMB Life; 2015 May; 67(5):331-7. PubMed ID: 25988524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
    Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
    Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.